Safety data and patterns of progression in met diagnostic subgroups in OAM4558g; A phase II trial evaluating MetMAb in combination with erlotinib in advanced NSCLC. Other Scholarly Work

Vashishtha, A, Patel, PH, Yu, W et al. (2011). Safety data and patterns of progression in met diagnostic subgroups in OAM4558g; A phase II trial evaluating MetMAb in combination with erlotinib in advanced NSCLC. . JOURNAL OF CLINICAL ONCOLOGY, 29(15), 10.1200/jco.2011.29.15_suppl.7604

cited authors

  • Vashishtha, A; Patel, PH; Yu, W; Bothos, JG; Simpson, J; Maneatis, T; Doessegger, L; Peterson, AC; Clement-Duchene, C; Robinet, G; Krzakowski, M; Blumenschein, GR; Goldschmidt, JH; Daniel, DB; Spigel, DR

authors

publication date

  • May 20, 2011

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • AMER SOC CLINICAL ONCOLOGY

volume

  • 29

issue

  • 15